These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2005-001360-31 A multicenter, randomised, double- blind, between-patient, dose finding study to assess the safety, tolerability and efficacy of three different dosages (500, 1000 and 2000 mcg/g) of ABIO 12/01 gel, i... bad-data
Completed, but no date, and reported results 2006-003643-23 Efficacy and tolerability study of a novel CNS drug ABIO 08/01 administered for 8 weeks to patients with generalised anxiety disorders bad-data
Completed, but no date, and reported results 2007-001060-80 A multicenter, parallel-group, double-blind, randomized, placebo-controlled, increasing-dose study, to evaluate preliminarily the clinical effects, the safety and tolerability of ABIO 08/01, in patien... bad-data
Completed, but no date, and reported results 2007-003372-18 A randomised, double-blind, placebo controlled study to assess the safety and the efficacy of neridronate 100 mg - 4 i.v. infusions in a course of 10 days treatment - in patients with algodystrophic s... bad-data
Completed, but no date, and reported results Terminated 2007-005195-14 A monocentre, randomised, double-blind, between-patient study to compare the effect of Vitamin D 300.000 IU orally vs placebo on bone metabolism, muscolar function, vascular system and infection in pa... bad-data
Completed, but no date, and reported results 2014-001156-28 A randomized, double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administrations, in patients with Complex Regiona... bad-data
Reported results Terminated 2018-002081-39 A randomised, double-blind, parallel-group, multicenter, placebo-controlled, dose-ranging study, to evaluate the efficacy and safety of clodronate ampoules at different dosages, after intra-articular ... 2021-07-01 due-trials
Ongoing 2018-003505-26 Randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of treatment with Neridronate 100 mg (4 infusions over a period of 10 days) in patients with transi... not-yet-due